Queens Medical Associates

Fresh Meadows, New York, United States
Oncologist in Queens, New York
176-60 Union Tpke #360, Queens, NY 11366

About Queens Medical Associates


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Advanced Viral Research Corp
1
Alliance for Clinical Trials in Oncology
1
Boehringer Ingelheim
1
Bristol-Myers Squibb
1
CTI BioPharma
1
Celgene
1
Dartmouth-Hitchcock Medical Center
1
Dendreon
1
Eli Lilly and Company
1
Memorial Sloan Kettering Cancer Center
1
Total Rows: 17

Clinical Trials at Queens Medical Associates


During the past decade, Queens Medical Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22000000110000111122Started TrialsCompleted Trails201520162017201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
2000-12-01
2008-10-01
Completed
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
2000-12-04
2014-03-17
Completed
2,104
Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
2001-02-01
Completed
250
Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
2003-01-01
2004-10-01
Terminated
350
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
2003-01-01
2007-01-01
Completed
855
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
2007-09-01
Completed
Palliative Care Study in Patients With Advanced Cancer
2005-03-01
2006-08-01
Terminated

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Queens Medical Associates" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Advanced Viral Research Corp" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Queens Medical Associates" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NYC Health & Hospitals/ Lincoln Medical Center" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 2Hoffmann-La Roche: 2Advanced ViralResearch Corp: 1Advanced ViralResearch Corp: 1Alliance for ClinicalTrials in Oncology: 1Alliance for ClinicalTrials in Oncology: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1CTI BioPharma: 1CTI BioPharma: 1Celgene: 1Celgene: 1Dartmouth-HitchcockMedical Center: 1Dartmouth-HitchcockMedical Center: 1Dendreon: 1Dendreon: 1Eli Lilly and Company: 1Eli Lilly and Company: 1

Created with Highcharts 11.1.0Top CollaboratorsGenentech, Inc.: 2Genentech, Inc.: 2Bayer: 1Bayer: 1Cancer and LeukemiaGroup B: 1Cancer and LeukemiaGroup B: 1NYC Health & Hospitals/Lincoln Medical Center:1NYC Health & Hospitals/Lincoln Medical Center:1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1New York City Healthand HospitalsCorporation: 1New York City Healthand HospitalsCorporation: 1New York PresbyterianQueens: 1New York PresbyterianQueens: 1North Central CancerTreatment Group: 1North Central CancerTreatment Group: 1Queens Medical Associates: 1Queens Medical Associates: 1SWOG Cancer ResearchNetwork: 1SWOG Cancer ResearchNetwork: 1

Clinical Trials Conditions at Queens Medical Associates


According to Clinical.Site data, the most researched conditions in "Queens Medical Associates" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced Prostate Cancer" (1 trials), "Cancer" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Queens Medical Associates" in a lesser frequency.

Clinical Trials Intervention Types at Queens Medical Associates


Most popular intervention types in "Queens Medical Associates" are "Drug" (16 trials), "Biological" (2 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Rituximab" (2 trials), "docetaxel" (2 trials), "fluorouracil" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Queens Medical Associates


The vast majority of trials in "Queens Medical Associates" are 15 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Queens Medical Associates


Currently, there are NaN active trials in "Queens Medical Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Queens Medical Associates, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Queens Medical Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 14Phase 3: 14Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 13Completed: 13Active, not recruiting: 2Active, not recruiting: 2Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1